News - Reyataz

Filter

Current filters:

Reyataz

Popular Filters

European Commission OKs Novartis’ Rasitrio and new label for Bristol-Myers’ Reyataz

28-11-2011

Following a positive advisory recommendation in September, the European Commission has now approved Swiss…

Anti-viralsBristol-Myers SquibbCardio-vascularEuropeNovartisPharmaceuticalRasitrioRegulationReyataz

Bristol-Myers in licensing deal with Gilead for combination HIV pill

26-10-2011

US drug major Bristol-Myers Squibb (NYSE: BMY) has entered into a licensing accord with biotech firm…

Anti-viralsBiotechnologyBristol-Myers SquibbcobicistatGilead SciencesLicensingPharmaceuticalReyataz

Back to top